Chris Savile
Chief Executive Officer en WILLOW BIOSCIENCES INC. .
Fortuna: 69 758 $ al 31/03/2024
Perfil
Chris Savile is currently the President, Chief Executive Officer & Director at Willow Biosciences, Inc. Prior to this, he held the position of Executive Director-Commercial Operations at Precigen, Inc. from 2015 to 2019.
Before that, he was an Associate Director-Business Development at Codexis, Inc. from 2014 to 2015.
Dr. Savile obtained his doctorate degree from McGill University in 2005.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
WILLOW BIOSCIENCES INC.
0.74% | 12/04/2024 | 917 870 ( 0.74% ) | 69 758 $ | 31/03/2024 |
Cargos activos de Chris Savile
| Empresas | Cargo | Inicio |
|---|---|---|
| WILLOW BIOSCIENCES INC. | Chief Executive Officer | 28/03/2023 |
Antiguos cargos conocidos de Chris Savile.
| Empresas | Cargo | Fin |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 01/01/2019 |
| CODEXIS, INC. | Corporate Officer/Principal | 01/04/2015 |
Formación de Chris Savile.
| McGill University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CODEXIS, INC. | Process Industries |
| PRECIGEN, INC. | Health Technology |
| WILLOW BIOSCIENCES INC. | Commercial Services |
- Bolsa de valores
- Insiders
- Chris Savile
